drugset / Trial / NCT06211179
A Study to Assess the Relative Bioavailability of 5 mg Mavacamten Opened Capsule Administered Via Nasogastric Tube Compared to Intact Oral 5 mg Mavacamten in Healthy Participants
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study to assess the relative bioavailability of 5 mg Mavacamten opened capsule administered via nasogastric tube compared to intact oral 5 mg Mavacamten in healthy volunteers.
Timeline
- Start
- 2024-01-10
- Primary completion
- 2024-06-13
- Completion
- 2024-06-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mavacamten | Small molecule | 5 mg | Oral |
Indications
No indication recorded.